![]() | Up a level |
Lawless, Sarah, Sbianchi, Giulia, Morris, Curly, Iacobelli, Simona, Bosman, Paul, Blaise, Didier, Remenyi, Peter, Byrne, J. L., Mayer, Jiri, Apperley, Jane, Lund, Johan, Kobbe, Guido, Schaap, Nicolaas, Isaksson, Cecilia, Lenhoff, Stig, Basak, Grzegorz, Touzeau, Cyrille, Wilson, Keith M. O., Gonzalez Muniz, Soledad, Scheid, Christof, Browne, Paul, Anagnostopoulos, Achilles, Rambaldi, Alessandro, Jantunen, Esa, Kroeger, Nicolaus, Schoenland, Stefan, Yakoub-Agha, Ibrahim and Garderet, Laurent (2021). IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study. Clin. Lymphoma Myeloma Leuk., 21 (10). S. 686 - 694. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669
Sahebi, Firoozeh, Iacobelli, Simona, Sbianchi, Giulia, Koster, Linda, Blaise, Didier, Remenyi, Peter, Russell, Nigel H., Ljungman, Per, Kobbe, Guido, Apperley, Jane, Trneny, Marek, Krejci, Marta, Wiktor-Jedrzejczak, Wieslaw, Sanchez, James F., Schaap, Nicolaas ORCID: 0000-0001-7696-4752, Isaksson, Cecilia, Lenhoff, Stig, Browne, Paul
ORCID: 0000-0001-5310-1487, Scheid, Christof, Wilson, Keith M. O., Yakoub-Agha, Ibrahim
ORCID: 0000-0003-4524-8782, Muniz, Soledad Gonzalez, Schoenland, Stefan, Morris, Curly, Garderet, Laurent and Kroeger, Nicolaus
(2018).
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
Biol. Blood Marrow Transplant., 24 (5).
S. 930 - 937.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1523-6536